Immunomedics Chairman Buys $19 Million More in Stock.
(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132,...
Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).
A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied...
Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.
NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage...
Added to Watch List $1.32, Dyadic Inc (DYAI) Announces $5 Million Stock Buyback.
CLICK TO VIEW REPORT
Adding Dicerna (DRNA) $3.30 to Watch List.
Adding Dicerna (DRNA) $3.30 to Watch List.
How fun would it be to sell a $3.00 idea (IMMU) at...
Adding Immunomedics (IMMU) $3.00 to Watch List.
Biotech Stock Review Initiates Coverage.
Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
Largest Stem Cell Investor Conference Set to Be Held in New York City
Where Stem Cell Science, Meets Wall Street
NEW YORK, NY--(Marketwired - Oct 6, 2015) - Investor Conference Network...
CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.
“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”
Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.
Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for...